6-7 NEWS
Eli Lilly and InnoCare agree on $3.3bn deal; FDA gives fenebrutinib for MS priority review

8-9 NEWS
NICE recommends J&J’s Darzalex combo; Moderna and Pfizer/BionTech COVID vaccines approved

10-11 DERMATOLOGY NEWS
Lilly’s alopecia drug approved for teens by FDA; MSD results for hidradenitis suppurativa

12 DARWIN’S MEDICINE
Taking sides – colleagues and competitors

13 THE GLOBAL HEAT THREAT
Is climate change the new pandemic?

14 A FIVE-STEP FRAMEWORK
The decisions that influence performance

15 ROLE MODELLING
Leading by example, with heart

16-17 THE NEXT PHASE OF ORAL GLP-1s – THREE WAVES OF INNOVATION PHARMA LEADERS SHOULD WATCH
Fidelity has put 2026 sales at $1.5bn to $2.8bn, Citi has forecast peak annual revenues above $40bn, and Clarivate projects $11.1bn in obesity sales across the G7 by 2031. If other programmes make it through the clinic, oral GLP- 1s could become a genuine class rather than just a single blockbuster product

19-21 DEVELOPING NEW TREATMENTS FOR RARE DISEASES
In 2025, rare diseases were declared a global health priority and investment in rare disease biotechs has increased since the FDA’s Priority Review Voucher scheme was renewed – a rare opportunity to incentivise new treatments, as around one in 17 people are forecast to be affected by a rare disease during their lifetime, including over 3.5 million people in the UK

26-28 USING THE POWER OF SOCIAL MEDIA TO BREAK THROUGH
Connecting with patients and HCPs through social media channels needs care and consistency – influence comes from spotting gaps in understanding and helping people find the information they’re looking for

32-33 PHARMA’S DIGITAL FRONT DOOR OPENS
Websites and HCP portals are making real gains across Europe – but AI-mediated discovery is quietly resetting the standard for content that HCPs and machines can trust

34-35 CONNECTING GLOBAL TALENT WITH UK GROWTH
Earlier this year, the UK government widened fast-track endorsement for academic and research appointments – what does this expanded global talent route mean for life sciences?

October 2026